期刊文献+

miR-581对结直肠癌SW620细胞增殖能力的影响 被引量:4

Effects of miR-581 overexpression on proliferation of human colorectal cancer SW620 cells
下载PDF
导出
摘要 目的:探讨miR-581对结直肠癌SW620细胞增殖能力的影响。方法:分别用携带miR-581基因的慢病毒颗粒(LV-miR-581-GFP)和miR-581 mimics(miR-581)转染人结肠癌细胞株SW620作为实验组;用对照组病毒颗粒(LV-GFP)和对照组mimics(Vector)转染SW620细胞株作为阴性对照组。用实时荧光定量PCR(qRT-PCR)检测各组细胞中miR-581的mRNA表达水平;CCK8和克隆形成实验检测细胞增殖能力和克隆形成能力的变化。结果:实验组SW620细胞中miR-581表达较对照组明显增高(P<0.05);CCK8和克隆形成实验显示过表达实验组细胞的增殖及克隆形成能力较对照组明显增强(P<0.05)。结论:miR-581对结直肠癌SW620细胞的增殖具有促进作用。 Objective:To investigate the role of miR-581 overexpression on the proliferation of human colorectal cancer cell line SW620. Methods: The expression group, colorectal cancer SW620 cells were transfected with recombinant lentivirus vector (LV-miR- 581 ) and miR-581 mimics( miR-581 ) ,the negative control group were transfected with negative control lentiviral vector (LV-GFP) and negative control mimics (vector). The mRNA expression of miR-581 was identified by qRT-PCR. Proliferation of the cells were detected by CCK8 assary and colony forming assary. Results: The expression of miR-581 at mRNA significantly increased in LV-miR-581 group compared with control groups were detected by qRT-PCR ( P〈0. 05 ). Up-regulation of miR-581 markedly enhanced human colorectal cancer SW620 cells proliferation than those in the cells transfected with control vector ( P〈0. 05 ). Conclusion : Forced expression of miR-581 accelerates the proliferation of colorectal cancer SW620 cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第2期252-255,共4页 Chinese Journal of Immunology
基金 国家自然科学基金项目(81560407)资助
关键词 miR-581 结直肠癌 增殖 miR-581 Colorectal cancer Proliferation
  • 相关文献

参考文献2

二级参考文献16

  • 1Keenan JE ,Speicher PJ,Thacker JK,et al. The preventive surgical site infection bundle in colorectal surgery:an effective approach to surgical site infection reduction and health care cost savings [ J ]. JAMA Surg,2014,149 (10) :1045-1052. 被引量:1
  • 2Zhang X, Xu J, Liu H, et al. Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial[ J]. Med Oncol,2014,31 (10) :226. 被引量:1
  • 3Han K, Jin J, Maia M, et al. Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trial [ J ]. AAPS J,2014,16 (5) : 1056-1063. 被引量:1
  • 4Dvinge H, Git A, Graf S, et al. The shaping and functional consequences of the microRNA landscape in breast cancer [ J ]. Nature,2013,497 (7449) :378-382. 被引量:1
  • 5Ferraro A,Kontos CK,Boni T,et al. Epigenetic regulation of miR- 21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network ( miR-21-1TGBeta4-PDCIM ) as predictor of metastatic tumor potential[ J]. Epigenetics ,2014,9 ( 1 ) : 129-141. 被引量:1
  • 6Tu K,Li C,Zheng X,et al. Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth [ J ].Oncol Rep ,2014,32 (4) : 1571-1577. 被引量:1
  • 7Chang YY, Kuo WH, Hung JH, et al. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing[ J]. Mol Cancer,2015,14 ( 1 ) :36. 被引量:1
  • 8Lin YH,Wu MH,Liao CJ,et al. Repression of mieroRNA-130b by thyroid hormone enhances cell motility [ J ]. J Hepatol, 2015, (62) : 1328-1340. 被引量:1
  • 9Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003- 2005 : a population-based study [ J ]. Int J Cancer, 2015,136 ( 8 ) : 1921-1930. 被引量:1
  • 10Loupakis F, Cremolini C, Masi G, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer [J]. N Engl J Med,2014,371 (17) :1609-1618. 被引量:1

共引文献14

同被引文献33

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部